industry pr

Press release news from the public relations clients of Tiziani Whitmyre, Inc.


August 18th, 2015

At-Line Analysis of Sulfur in Fuels Using ED-XRF Spectroscopy is Detailed in New Application Brief

A new application brief explaining how the use of ED-XRF spectroscopy for at-line analysis of sulfur in fuels can cut production delays from days to minutes is available to download from http://xrf.spectro.com/spectroscout/at-line/analysis-of-sulfur-in-fuels.

Sulfur content is a key quality determinant for many petroleum products and the knowledge of the content of sulfur in fuels impacts processing and assists compliance with government regulations. Traditionally, the analysis of sulfur in fuels has been performed in the laboratory using XRF spectroscopy. However, the practice often results in production delays due to the time required to transport samples from the line to the laboratory as well as the time samples spend waiting in queue in the lab to be processed.

Now, a new generation of portable ED-XRF spectrometers is enabling rapid and accurate at-line analysis — right at the production line — for many applications requiring the detection of sulfur in fuels. According to the new application brief, “At-Line Analysis of Sulfur in Fuels According to ASTM D4294 Using ED-XRF Spectroscopy,” with a portable ED-XRF spectrometer, at-line analysis can be performed once the sample is collected from any process point — and it fully conforms to the ASTM D4294 requirement for analysis time of 1 to 5 min per sample.”

In addition to an introduction and discussion of the need for at-line QC, the new brief discusses the advances and advantages of portable ED-XRF technology for at-line analysis of sulfur in fuels. The brief also documents, in detail, the at-line analysis of a series of samples using a SPECTROSCOUT portable spectrometer equipped with a transmission target X-ray tube (Rh target), a filter changer, a helium purge system and a high resolution large area SDD. The resolution of the SDD used amounted to <155 eV (Mn Kα) at an input count rate of up to 200,000 cps. The results from the tests showed compliance with criteria set out in ASTM D4294.

The brief concludes with helpful guidance for the specification and selection of an at-line ED-XRF system, including factors to consider when comparing ED-XRF spectrometers — and notes the vast differences in instrument performance, ease of use, and suitability for the at-line analysis of sulfur in fuels.

Download the new brief, “At-Line Analysis of Sulfur in Fuels According to ASTM D4294 Using ED-XRF Spectroscopy,” from http://xrf.spectro.com/spectroscout/at-line/analysis-of-sulfur-in-fuels. The brief is authored by SPECTRO Analytical Instruments, a leading global supplier of analytical instruments for optical emission and X-ray fluorescence spectrometry.

About SPECTRO:

SPECTRO, a unit of the Materials Analysis Division of AMETEK, Inc., manufactures advanced instruments, develops the best solutions for elemental analysis for a broad range of applications, and provides exemplary customer service.

SPECTRO’s products are known for their superior technical capabilities that deliver measureable benefits to the customer. From its foundation in 1979 until today, more than 30,000 analytical instruments have been delivered to customers around the world.

AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical products with more than 15,000 colleagues at nearly 150 operating locations and sales and service operations in the United States and 30 other countries around the world.

Tags: , , , , , , ,


July 30th, 2015

First Commons Bank Reaches $282 Million in Total Assets in Less Than Six Years

NEWTON, MASS. —  July 30, 2015  —  First Commons Bank of Newton, Mass., today reported that it achieved $282 million in Total Assets as of June 30, 2015, a $28 million or +11.0% increase over the December 31, 2014 Total Asset level of $254 million. Only $1.8 million of asset growth was due to the continuation of a 2014-2015 Capital Raise that ended in January. The balance of growth came principally in the core deposit areas of checking, money market and CDs under $250,000. Total deposits of $240 million reflect an increase of $27.0 million or +12% versus the December 31, 2014 balance. Net Loans of $234 million reflect an increase of $21 million or +10.0% versus December 31, 2014.

Tony Nuzzo, Chairman, President and CEO of First Commons Bank said, “We are pleased with our growth in loans and deposits, our increase in quarter-over-quarter profitability, and our high credit quality as we maintain a ratio of non-performing loans to performing loans of 0.00%.”

Net income for the 3-month period ended June 30, 2015 increased 23% to $254 thousand versus $207 thousand for the 3-month period ended March 31, 2015.

Tangible Book Value on June 30th 2015 was $9.93 per share with nearly $31 million in equity and a Tier 1 Capital Ratio to Average Assets for the quarter of 11.30%.

First Commons Bank’s financial results are available on the FDIC’s Web site at: https://goo.gl/hXeuVV.

About First Commons Bank

First Commons Bank, N.A., is a nationally chartered, FDIC-insured full-service community bank, dedicated to serving the businesses and individuals of Newton, Wellesley, Waltham, and eastern Massachusetts. The bank opened for business on July 22, 2009. Locations include its headquarters at 718 Beacon Street in Newton Centre, Mass., and 161 Linden Street in Wellesley, Mass. Visit the First Commons Bank website at http://www.firstcommonsbank.com Follow the bank on Facebook at http://facebook.com/firstcommonsbank and on Twitter at http://twitter.com/firstcommonsbnk.

Tags: , , , , ,


July 29th, 2015

Which ICP-OES Optical Technology Offers Superior Performance: Echelle or ORCA? Whitepaper Explores Differences

Optical Superiority WP final_Page_01The issue of which ICP-OES optical technology delivers the superior performance — Echelle or ORCA — is explored in a new whitepaper available to download at http://icp-oes.spectro.com/echelle-vs-orca.

Today’s modern ICP-OES models take one of two approaches to optical design: echelle-based or Rowland Circle-based (as in Optimized Rowland Circle Alignment, or ORCA) technologies. Laboratory managers require a thorough understanding of each in order to select the appropriate instrument for their specific elemental analysis applications.

The new paper, “Which ICP-OES Optical Technology Offers Superior Performance? Echelle vs. ORCA” discusses the key advantages and disadvantages of both approaches to ICP-OES design.

 

In the discussion of the echelle optical technology, the paper explores the issue of light loss and stray light; optical limitations; spectral order overlap; wavelength-dependent resolution; problematic radial-view performance; and supplementing or replacing radial-view instruments with axial-view or dual-view systems.

In a review of the ORCA optical technology for spectrometers, the paper explores the topics of light loss; optical performance; spectral order overlap; wavelength resolution; radial-view performance, and other considerations.

The new whitepaper, “Which ICP-OES Optical Technology Offers Superior Performance? Echelle vs. ORCA is available for download at http://icp-oes.spectro.com/echelle-vs-orca, from SPECTRO Analytical Instruments, a leading global supplier of analytical instruments for optical emission and X-ray fluorescence spectrometry for elemental analysis.

About SPECTRO:

SPECTRO, a unit of the Materials Analysis Division of AMETEK, Inc., manufactures advanced instruments, develops the best solutions for elemental analysis for a broad range of applications, and provides exemplary customer service.

SPECTRO’s products are known for their superior technical capabilities that deliver measurable benefits to the customer. From its foundation in 1979 until today, more than 30,000 analytical instruments have been delivered to customers around the world.

AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical products with more than 15,000 colleagues at nearly 150 operating locations and sales and service operations in the United States and 30 other countries around the world.

For more information, visit http://www.spectro.com or email spectro.info@ametek.com.

Tags: , , , , ,


July 22nd, 2015

Selecting the Right Valve Types to Improve Process Cooling: New ASCO Whitepaper

FLORHAM PARK, N.J., July 22, 2015 — Help for engineers with selecting the right valve types to help improve process cooling throughout a range of industries is available in a new whitepaper that uses winemaking to illustrate the suggested tradeoffs and advantages involved in optimum valve selection.

The new paper, “Great Wine Coolers: Selecting valves to improve process cooling in winemaking and other industries,” explains that while the cooling process in industrial winemaking is fairly straightforward, it can highlight how valves can function as surprisingly important ingredients in improving a wide variety of process cooling applications.

Key takeaways from the whitepaper include:

  • The multiple choices in selecting valve types for any type of industrial cooling application
  • Diaphragm valves are popular and affordable; may encounter plugging problems
  • Ball valves avoid plugging; are relatively expensive and maintenance-intensive
  • Angle-body piston valves are slightly more expensive than diaphragm valves; offer exceptionally long life
  • An exclusive direct-acting temperature control valve, though initially expensive, provides ultimate economy and most advanced control

Download the free whitepaper, “Great Wine Coolers: Selecting valves to improve process cooling in winemaking and other industries,” at https://goo.gl/SD7RET, from ASCO Numatics, the world’s leading manufacturer of comprehensive fluid automation, flow control, and pneumatics solutions.

About ASCO Numatics

ASCO Numatics, an Emerson company, offers comprehensive fluid automation solutions, including fluid control and fluid power products, for a wide range of industry-focused applications. The ASCO Numatics product line in North America consists of more than 50,000 valves, an extensive selection of air preparation equipment, and a full line of actuation products. ASCO products include solenoid pilot valves, angle body piston valves, linear indicators, redundant control systems, and pressure sensors. The Numatics line covers valve manifolds, cylinders, grippers, filters, regulators, and lubricators. For more information about ASCO Numatics products, visit www.asconumatics.com.

About Emerson

Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets around the world.  The company is comprised of five business segments: Process Management, Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions. Sales in fiscal 2014 were $24.5 billion. For more information, visit Emerson.com.

Tags: , , ,


July 20th, 2015

Free Literature News: SPECTROSCOUT Portable ED-XRF Analyzers

SCOUT Family pg1FREE brochure details new SPECTROSCOUT portable ED-XRF analyzers that bring lab-quality elemental analysis for field or offsite testing for environmental screening, petrochemical exploration as well as laboratory and at-line quality control (QC) testing for processed and manufactured goods (chemicals, oil, metal surface coatings, pharmaceuticals, cosmetics, food, feedstock, etc.).

SPECTRO ANALYTICAL INSTRUMENTS
1.800.548.5809
http://xrf.spectro.com/wp-content/uploads/brochure_spectroscout_family.pdf

 

Tags: , , , , , , , , , , , , , , , ,


July 13th, 2015

PathMaker Neurosystems Receives Milestone Achievement Award for $200,000 from Massachusetts Life Sciences Center

PMNBoston, MA (July 13, 2015) PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing novel non-invasive systems for the treatment of neuromotor disorders, today announced that it is the recipient of a Milestone Achievement Program (MAP) award from the Massachusetts Life Sciences Center (MLSC).  The MAP award, in the amount of $200,000, will enable PathMaker to initiate engineering and development of a clinical-use version of its first product, MyoRegulatorTM, intended for the treatment of spasticity and muscle tone disorders in patients with neuromotor dysfunction. 

“The PathMaker team is honored to have been recognized with the MAP award,” said Nader Yaghoubi, M.D., Ph.D., President and Chief Executive Officer of PathMaker.  “The support of the MLSC MAP program will enable us to finance critical activities needed in preparation for human clinical trials.  The MLSC has developed an internationally-recognized model for catalyzing innovation that has been instrumental to the success of numerous life science companies based in the Commonwealth.”

PathMaker Neurosystems Inc. was founded to commercialize recent breakthrough advances in the development and clinical application of trans-spinal direct current stimulation (tsDCS) for patients with neuromotor disorders. tsDCS is a novel modality for non-invasive neuromodulation that has only emerged within the last five years, being driven by fundamentally new understandings of spinal circuit biology made by PathMaker’s scientific advisors and their clinical work in treating patients with paralysis, muscle weakness and muscle tone disorders.  More than 27 million patients in the US and Europe suffer disabilities due to stroke, cerebral palsy, multiple sclerosis, spinal cord injury, traumatic brain injury, Parkinson’s disease and other neurological disorders, and the breakthrough non-invasive technology that PathMaker is developing promises to open up entirely new methods of treating these patients.

The Massachusetts Life Sciences Center (MLSC) is a quasi-governmental investment agency that supports life sciences innovation, research, development and commercialization.  “We are pleased to be able to facilitate the efforts of PathMaker Neurosystems, an innovative neuromodulation company headquartered in Boston, Massachusetts,” said Pamela Norton, Vice President for Industry Relations and Programs at the MLSC. “We look forward to working with PathMaker as they advance a new generation of non-invasive technology for treating patients with neuromotor conditions.”

This announcement is not intended to be a commercial endorsement by the MLSC of any products or services provided or developed by the entities referenced in this release

About PathMaker Neurosystems Inc.

PathMaker Neurosystems Inc. is a clinical-stage neuromodulation company founded to commercialize recent breakthrough advances in the development and clinical application of trans-spinal direct current stimulation (tsDCS) for patients with neuromotor disorders. More than 27 million patients in the US and Europe suffer disabilities due to stroke, cerebral palsy, multiple sclerosis, spinal cord injury, traumatic brain injury, Parkinson’s disease and other neurological disorders, and the breakthrough non-invasive technology that PathMaker is developing promises to open up entirely new methods of treating these patients.  For more information, please visit www.pmneuro.com.

About Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences. For more information, visit www.masslifesciences.com.

 

Tags: , , , , , , ,


July 7th, 2015

At-Line Micronutrient Analysis Using ED-XRF Spectroscopy is Detailed in New Application Brief

Kleve, Germany — July 7, 2015 — The ability to conduct at-line micronutrient analysis using ED-XRF spectroscopy at the point of production is detailed in a new application brief from SPECTRO Analytical Instruments, available to download at http://xrf.spectro.com/micronutrient.

The brief, At-Line Micronutrient Analysis Using ED-XRF Spectroscopy at the Point of Production,” details the significant advantages of at-line elemental analysis for product and consistency in micronutrient analysis — while maximizing production throughput.

Both the recent use of inductively coupled plasma-optical emission spectrometry (ICP-OES) and alternate colorimetric methods for manufacturing quality control purposes present drawbacks for producers, according to the paper. These include the need to transport samples from the production line to a laboratory for analysis, and the lengthy time that is required for extensive sample preparation.

In contrast, the advantages of at-line elemental analysis are many. The foremost benefit, according to the brief, is that with a new-generation portable ED-XRF spectrometer, elemental analysis can be performed directly on a sample and usually with little preparation — at the production line or anywhere in the plant.

In addition, the use of a new, carefully-selected ED-XRF instrument in performing at-line elemental analysis can deliver the level of accuracy previously found only in the laboratory. Moreover, the paper notes, employing at-line elemental analysis can help boost production throughput, reduce costs, and provide the manufacturing process with far more flexibility than ever before.

As a guide, the brief also provides a series of critical factors for readers to consider when specifying and comparing various at-line ED-XRF spectrometers for micronutrient analysis.

The new application brief, “At-Line Micronutrient Analysis Using ED-XRF Spectroscopy at the Point of Production,” is available for download at http://xrf.spectro.com/micronutrient. The application brief is authored by SPECTRO Analytical Instruments, a leading global supplier of analytical instruments for optical emission and X-ray fluorescence spectrometry.

About SPECTRO:

SPECTRO, a unit of the Materials Analysis Division of AMETEK, Inc., manufactures advanced instruments, develops the best solutions for elemental analysis for a broad range of applications, and provides exemplary customer service.

SPECTRO’s products are known for their superior technical capabilities that deliver measureable benefits to the customer. From its foundation in 1979 until today, more than 30,000 analytical instruments have been delivered to customers around the world.

AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical products with more than 15,000 colleagues at nearly 150 operating locations and sales and service operations in the United States and 30 other countries around the world.

Tags: , , , , ,


June 19th, 2015

PathMaker Neurosystems Inc. Named as Healthcare Semi-Finalist in Hello Tomorrow Challenge Global Start-Up Competition

BOSTON, June 19, 2015 – PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing novel non-invasive systems for the treatment of neuromotor disorders, announced that it was named as one of five healthcare semi-finalists selected to advance to the finale of the “Hello Tomorrow” Challenge, the global start-up competition, being held June 24-26.

Hello Tomorrow” is a global competition covering all major fields of technology that promotes the most innovative breakthrough technologies being developed by entrepreneurs who are taking on the most important challenges in the world today. This year, there were 3,600 proposal submitted from 90 countries.

PathMaker Neurosystems was selected as one of only five healthcare semi-finalists selected to present next week in the competition finale. “The PathMaker team is tremendously excited and honored to be invited to present as a semi-finalist at the Hello Tomorrow Challenge,” said Nader Yaghoubi, M.D., Ph.D., President and Chief Executive Officer of PathMaker. “Our technology prototypes have already changed the lives of numerous patients with neuromotor dysfunction.  We are committed to rapidly moving forward our pioneering non-invasive technology so that we can treat a global backlog of patients waiting for a therapy that can help them.”

PathMaker Neurosystems Inc. was founded to commercialize recent breakthrough advances in the development and clinical application of trans-spinal direct current stimulation (tsDCS) for patients with neuromotor disorders. tsDCS is a novel modality for non-invasive neuromodulation that has only emerged within the last five years, being driven by fundamentally new understandings of spinal circuit biology made by our Company’s scientific advisors and their clinical work in treating patients with paralysis, muscle weakness and muscle tone disorders.  More than 27 million patients in the US and Europe suffer disabilities due to stroke, cerebral palsy, multiple sclerosis, spinal cord injury, traumatic brain injury, Parkinson’s disease and other neurological disorders, and the breakthrough non-invasive technology that PathMaker is developing promises to open up entirely new methods of treating these patients.

About PathMaker Neurosystems Inc.
PathMaker Neurosystems Inc. is a clinical-stage neuromodulation company founded to commercialize recent breakthrough advances in the development and clinical application of trans-spinal direct current stimulation (tsDCS) for patients with neuromotor disorders. More than 27 million patients in the US and Europe suffer disabilities due to stroke, cerebral palsy, multiple sclerosis, spinal cord injury, traumatic brain injury, Parkinson’s disease and other neurological disorders, and the breakthrough non-invasive technology that PathMaker is developing promises to open up entirely new methods of treating these patients.  For more information, please visit www.pmneuro.com.

Tags: , , , , , ,


June 17th, 2015

ASCO Introduces 362 and 562 Series Stainless Steel Spool Valves for Valve Automation in Oil and Gas Markets

ASCO 362 and 562Florham Park, New Jersey, U.S.A., (June 17, 2015) — ASCO Numatics has introduced the 362 and 562 Series of stainless steel spool valves for control valve automation in the upstream, midstream, and downstream oil and gas markets.

“The 362 and 562 Series valves incorporate ASCO’s proven solenoid technology for unequaled reliability in mission-critical oil and gas applications,” said Robert W. Kemple, Jr., executive vice president, sales and marketing – Americas, ASCO Numatics. “Unlike some competitors, we design and manufacture our own solenoids to ensure the highest quality and longest product life.”

The 362 and 562 Series valves offer low-power solenoid versions that consume only 1.4 watts, making them the most energy-efficient valves in their class. A 0.55 watt solenoid option is coming soon that will be ideal for remote applications requiring alternate energy sources.

The ASCO 562 Series is a four-way spool valve designed for double-acting process valves. The 362 Series is a three-way valve made for single-acting process valve applications. Both valve lines are available in ¼-inch, 316L stainless steel construction for corrosion resistance in harsh environments.

“Our new valves have extensive manual and low-temperature versions,” said Kemple. “In addition, ASCO’s solenoid options include a low-power solenoid with UL, CSA, ATEX, and IECEX hazardous location approvals that will support global designs. This flexibility makes the 362 and 562 Series spool valves ideal for a wide variety of upstream and mid-stream oil and gas, plus downstream hydrocarbon and petrochemical processing applications,” he said.

Popular constructions will be available for same-day shipping with no expediting fees via ASCO Express. The valves can be ordered through ASCO distributors and sales representatives. For more information, contact ASCO at 800-972-ASCO (2726), by e-mail at info-valve@ascovalve.com, or visit www.ascovalve.com/spoolvalve.

About ASCO Numatics

ASCO Numatics, an Emerson company, offers comprehensive fluid automation solutions, including fluid control and fluid power products, for a wide range of industry-focused applications. The ASCO Numatics product line in North America consists of more than 50,000 valves, an extensive selection of air preparation equipment, and a full line of actuation products. ASCO products include solenoid pilot valves, angle body piston valves, linear indicators, redundant control systems, and pressure sensors. The Numatics line covers valve manifolds, cylinders, grippers, filters, regulators, and lubricators. For more information about ASCO Numatics products, visit www.asconumatics.com.

About Emerson

Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets around the world.  The company is comprised of five business segments: Process Management, Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions. Sales in fiscal 2014 were $24.5 billion. For more information, visit Emerson.com.

Tags: , ,


June 16th, 2015

SPECTRO Introduces SPECTROLAB Spectrometers for Ultimate Performance in Metal Analysis

Kleve, Germany —June 16, 2015 — SPECTRO Analytical Instruments today introduced two new SPECTROLAB Arc/Spark optical emission spectrometers for high-performance metal analysis.

The new SPECTROLAB metal analyzers deliver ultrahigh speed of measurement, ultralow limits of detection, ultimate elemental flexibility, spectacular stability, and affordable cost of ownership to set new standards for elemental analysis in metals industry research and development (R&D) and process/quality control.

The new hybrid SPECTROLAB metal analyzer combines analog photomultiplier tube (PMT) detectors with digital charge coupled device (CCD) technology for ultra-accurate simultaneous measurements in R&D, trace metal measurement, and precious metals analysis.

The new breakthrough all-CCD technology SPECTROLAB spectrometer for metal analysis provides outstanding speed, accuracy, and flexibility for process control and QC of fabricated and finished goods.

Features of both new high-performance metal analyzers include:

  • Spectacular stability without compromise. Unlike conventional models, SPECTROLAB’s sealed, no-purge optical system maximizes light transmission stability, even in the far UV; its software utilizes sophisticated online drift correction measures; and its optimum correlation between analytical and reference lines provides the most stable measurement approach possible.
  • Ultralow limits of detection with improved background correction. Depending on application and analytes, SPECTROLAB can easily ascertain trace values in single parts per million (ppm).
  • Ultrahigh speed of measurement. The coupling of a high-energy plasma generator with SPECTRO’s unique dynamic pre-burn process delivers a lightning fast setup, accelerated sample throughput, and extremely low time to measurement in many applications.
  • Ultimate elemental flexibility, in most cases eliminating hardware reconfigurations. An optional software-extendable configuration enables changes to the elemental setup without requiring calibration.
  • Affordable cost of ownership. iCAL logic saves not only time but also cost for standardization samples. UV-PLUS purification eliminates expensive argon purging or vacuum pumps. Component relocations, advanced diagnostics, and other improvements ease maintenance and prevent downtime.
  • Excellent ease of use with a new user interface and new application profiles that are tailored to predetermined user requirements.

Both new SPECTROLAB high-performance OES spectrometers for metal analysis are immediately available from SPECTRO Analytical Instruments. For more information, visit http://www.spectro.com/lab or email spectro.info@ametek.com.

In addition, join the live webinar broadcast, “Metalmorphosis: Sparking a Revolution in High Performance Metal Analysis” on July 16, 2015, at 1:30 p.m. EDT. Register now at: http://oes.spectro.com/spectrolab/webinar.

SPECTRO Analytical Instruments is a leading global supplier of analytical instruments employing X-ray fluorescence, Arc/Spark, ICP-OES, and ICP-MS technology for the elemental analysis of materials in industry, research, and academia.

About SPECTRO:

SPECTRO, a unit of the Materials Analysis Division of AMETEK, Inc., manufactures advanced instruments, develops the best solutions for elemental analysis for a broad range of applications, and provides exemplary customer service.

SPECTRO’s products are known for their superior technical capabilities that deliver measureable benefits to the customer. From its foundation in 1979 until today, more than 30,000 analytical instruments have been delivered to customers around the world.

AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical products with more than 15,000 colleagues at nearly 150 operating locations and sales and service operations in the United States and 30 other countries around the world.

Tags: , , , , ,


B2B News is proudly powered by WordPress.
WordPress